CLINICAL PREDICTORS OF CARDIOVASCULAR OUTCOMES IN PATIENTS ON CELECOXIB, IBUPROFEN, AND NAPROXEN

Haris Riaz,Grant Reed,Qiuqing Wang,Lisa Wisniewski,Kathy Wolski,A. Lincoff,Steven Nissen

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2019）

引用 1|浏览12

暂无评分

摘要

The PRECISION trial established the cardiovascular (CV) safety of celecoxib was non-inferior to ibuprofen and naproxen in patients with non-steroidal anti-inflammatory drug (NSAID) dependent arthritis. Herein, we describe the clinical predictors of CV events in PRECISION.23,953 patients dependent

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要